Cns Pharmaceuticals Inc stock is traded at $3.46, with a volume of 1,039. It is down -0.52% in the last 24 hours and down -28.63% over the past month. CNS Pharmaceuticals Inc is a biotechnology company focused on developing therapies for serious diseases in neurology and oncology. The company is building a high-value pipeline for neurology and oncology indications. Its new corporate includes pivoting from a singular focus on glioblastoma multiforme and exploring out-licensing opportunities for its legacy assets, TPI 287 and Berubicin.
Previous Close:
$3.48
Open:
$3.59
24h Volume:
1,039
Relative Volume:
0.11
Market Cap:
$5.06M
Revenue:
-
Net Income/Loss:
-$16.49M
P/E Ratio:
-
EPS:
-$29.63
Net Cash Flow:
-$15.24M
1W Performance:
-10.08%
1M Performance:
-28.63%
6M Performance:
-30.06%
1Y Performance:
-48.33%
1-Day Range:
$3.44$3.59
1-Week Range:
$2.89$4.07
52-Week Range:
$1.90$10.54
Cns Pharmaceuticals Inc Stock (CNSP) Company Profile
Name
Cns Pharmaceuticals IncSector
HealthcareIndustry
BiotechnologyPhone
1-800-946-9185Address
2100 WEST LOOP SOUTH, HOUSTON, USAMarket Cap
Revenue
Net Income
Cash Flow
EPS